Invokana, Invokamet Get New Warning About Bone Fracture, Low Bone Mineral Density

(September 14, 2015, 11:23 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Sept. 10 said it added warnings to the label of Invokana and Invokamet diabetes drugs to warn of the increased risk of bone fractures and decreased bone mineral density....

Related Sections